HIGHLIGHTS
- who: Xianwen Hu from the Department of Nuclear Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China, Department of Obstetrics have published the article: Advances in the Application of Radionuclide-Labeled HER2 Affibody for the Diagnosis and Treatment of Ovarian Cancer, in the Journal: (JOURNAL)
SUMMARY
Ovarian cancer is the disease with the highest mortality rate after cervical cancer secondary to female reproductive tract malignant tumors; in 2020, 313,959 new patients with ovarian cancer and 207,252 new deaths from ovarian cancer were reported worldwide. Random replacement of these 13 amino_acid codons . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.